These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6848399)

  • 1. The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus.
    Pietri AO; Dunn FL; Grundy SM; Raskin P
    Diabetes; 1983 Jan; 32(1):75-81. PubMed ID: 6848399
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.
    Dunn FL; Pietri A; Raskin P
    Ann Intern Med; 1981 Oct; 95(4):426-31. PubMed ID: 7025720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients.
    Møller A; Rasmussen L; Ledet T; Christiansen JS; Christensen CK; Mogensen CE; Hermansen K
    Scand J Clin Lab Invest; 1986 Sep; 46(5):471-5. PubMed ID: 3529352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improved metabolic state in insulin-tested diabetes. Self-testing of blood or urine glucose on 2 days per week].
    Koschinsky T; Toeller M; Berger H; Dannehl K; Dopstadt K; Yousefian M; Gries FA
    Dtsch Med Wochenschr; 1984 Feb; 109(5):174-9. PubMed ID: 6365501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion.
    Pietri A; Dunn FL; Raskin P
    Diabetes; 1980 Dec; 29(12):1001-5. PubMed ID: 7002668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes.
    Howard BV; Abbott WG; Beltz WF; Harper IT; Fields RM; Grundy SM; Taskinen MR
    Metabolism; 1987 Sep; 36(9):870-7. PubMed ID: 3626866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump.
    Falko JM; O'Dorisio TM; Cataland S
    JAMA; 1982 Jan; 247(1):37-9. PubMed ID: 7031287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of glibenclamide and insulin on plasma high density lipoproteins in diabetics (author's transl)].
    Tamai T
    Nihon Naibunpi Gakkai Zasshi; 1980 Jan; 56(1):57-77. PubMed ID: 6766887
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
    Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
    Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Diabetic Dyslipidemia.
    Hirano T
    J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of continuous insulin delivery systems in treatment of diabetes mellitus.
    Kitabchi AE; Fisher JN; Matteri R; Murphy MB
    Adv Intern Med; 1983; 28():449-90. PubMed ID: 6340430
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
    Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of stanozolol in type II diabetes mellitus.
    Small M; Forbes CD; MacCuish AC
    Horm Metab Res; 1986 Sep; 18(9):647-8. PubMed ID: 3781480
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
    Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV
    J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Ishola M; Arrol S; Mackness M
    Arterioscler Thromb; 1992 Aug; 12(8):920-8. PubMed ID: 1637789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of LDL+VLDL oxidizability and hyperglycemia on blood cholesterol, phospholipid and triglyceride levels in type-I diabetic patients.
    Jain SK; McVie R; Meachum ZD; Smith T
    Atherosclerosis; 2000 Mar; 149(1):69-73. PubMed ID: 10704616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
    Bagdade JD; Dunn FL
    Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of diabetics with the Auto-syringe pump for the continuous infusion of insulin by the subcutaneous route].
    Costa Gil JE; Galloway JA; Wentworth SM
    Rev Clin Esp; 1982 Mar; 164(6):377-81. PubMed ID: 7051202
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes.
    Rosenstock J; Vega GL; Raskin P
    Diabetes; 1988 Apr; 37(4):393-7. PubMed ID: 3288528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein compositional abnormalities in type I diabetes: effect of improved glycaemic control.
    Pérez A; Caixàs A; Carreras G; Mauricio D; Pou JM; Serrat J; Gómez-Gerique J; de Leiva A
    Diabetes Res Clin Pract; 1997 May; 36(2):83-90. PubMed ID: 9229192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.